Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | ALPL | P05186 | 2/20 | 0.47 |
| ▸ | ALPI | P09923 | 2/20 | 0.47 |
| ▸ | ALPG | P10696 | 2/20 | 0.47 |
| ▸ | MAPT | P10636 | 3/20 | 0.46 |
| ▸ | MEN1 | O00255 | 3/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.46 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | CASP3 | P42574 | 1/20 | 0.44 |
| ▸ | SENP8 | Q96LD8 | 1/20 | 0.44 |
| ▸ | SENP7 | Q9BQF6 | 1/20 | 0.44 |
| ▸ | SENP6 | Q9GZR1 | 1/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16272652 | 0.87 | SMN1; SMN2 (0.44) | ALOX15MAPTMEN1KMT2AKDM4E | |
| SCHEMBL23850329 | 0.85 | ALOX15 (0.50) | ALOX15ALPLALPIALPGMAPT | |
| SCHEMBL2448079 | 0.84 | ALOX15 (0.57) | ALOX15ALPLALPIALPGMAPT | |
| SCHEMBL28442553 | 0.84 | ALOX15 (0.49) | ALOX15ALPLALPIALPGMAPT | |
| SCHEMBL28937245 | 0.84 | ALOX15 (0.49) | ALOX15ALPLALPIALPGMAPT | |
| SCHEMBL16272656 | 0.83 | MAPT (0.41) | MAPTMEN1KMT2AKDM4EHPGD | |
| SCHEMBL24533746 | 0.81 | ALOX15 (0.46) | ALOX15ALPLALPIALPGMAPT | |
| SCHEMBL29271582 | 0.80 | ALOX15 (0.45) | ALOX15ALPLALPIALPGMAPT | |
| SCHEMBL20029822 | 0.79 | SMN1; SMN2 (0.50) | MAPTMEN1KMT2AKDM4ENPC1 | |
| SCHEMBL20029826 | 0.78 | KMT2A (0.46) | MAPTMEN1KMT2AKDM4EHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 191 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-118355117-A | Oligonucleotide compositions and methods thereof | 波涛生命科学有限公司 | 2024-07-16 | — | — | CN | disclosed |
| CN-111936487-B | Compounds for the treatment of kinase dependent disorders | 埃克塞里艾克西斯公司 | 2024-07-09 | — | — | CN | disclosed |
| CN-111936136-B | Novel imidazopyrimidine compounds and uses thereof | 儿童医学中心公司 | 2024-07-05 | — | — | CN | disclosed |
| CN-113710660-B | DOT1L degradation agent and application thereof | 达纳-法伯癌症研究公司 | 2024-07-02 | — | — | CN | disclosed |
| CN-112312909-B | Compounds for the treatment of kinase dependent disorders | 埃克塞里艾克西斯公司 | 2024-07-02 | — | — | CN | disclosed |
| CN-114751920-B | Antitumor compounds | 法马马有限公司 | 2024-06-07 | — | — | CN | disclosed |
| CN-114736219-B | Antitumor compounds | 法马马有限公司 | 2024-06-07 | — | — | CN | disclosed |
| CN-118139977-A | Double-stranded oligonucleotide compositions and methods relating thereto | 波涛生命科学有限公司 | 2024-06-04 | — | — | CN | disclosed |
| CN-118139629-A | Compositions and methods for editing MECP2 transcripts | 波涛生命科学有限公司 | 2024-06-04 | — | — | CN | disclosed |
| CN-118139851-A | Antitumor compounds | 法马马有限公司 | 2024-06-04 | — | — | CN | disclosed |
| CN-106068325-A | CHIRAL DESIGN | 波涛生命科学有限公司 | 2016-11-02 | — | — | CN | disclosed |
| CN-105960265-A | Method for treating wound healing using chemically modified oligonucleotides | 阿克赛医药公司 | 2016-09-21 | — | — | CN | disclosed |
| CN-103224474-B | The synthesis of tetracycline and the like | 哈佛大学校长及研究员协会 | 2016-08-03 | — | — | CN | disclosed |
| CN-105814112-A | Aliphatic polycarbonate-based surface active agents | 萨索尔化学品（美国）有限公司 | 2016-07-27 | — | — | CN | disclosed |
| CN-102209532-B | Method for reducing small, dense LDL particles | METABOLEX INC | 2015-07-22 | — | — | CN | disclosed |
| CN-102365025-A | Conjugate-based systems for controlled drug delivery | SMARTCELLS INC | 2012-02-29 | — | — | CN | disclosed |
| CN-102014897-A | Compounds, compositions and methods for making the same | SIGNUM BIOSCIENCES INC | 2011-04-13 | — | — | CN | disclosed |
| CN-1373660-A | Method for treating chronic pain using MEK inhibitors | WARNER LAMBERT CO (US) | 2002-10-09 | — | — | CN | disclosed |
| CN-1348373-A | Use of 17-ketosteroids for the treatment of malaria and Trypanosomiasis | HOLLIS EDEN PHARMACEUTICALS (US) | 2002-05-08 | — | — | CN | disclosed |
| CN-1238762-A | Piperidine compounds | GILEAD SCIENCES INC (US) | 1999-12-15 | — | — | CN | disclosed |